Category Archives: Public Policy

Latest From Public Policy

Huffington Post: Data Exclusivity: Getting the Balance Right

Huffington Post: Data Exclusivity: Getting the Balance Right      A great article on the downsides of cutting or removing data exclusivity provisions for biologics.  The article points out that data protection is needed to enhance safety and create incentives to research and produce new innovative drugs that cost billions of dollars.  However, the author argues that the period must be limited somehow (not 50 years) to ensure generics can entire the market and lower costs.    Finally, the author states that lowering the data exclusivity Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BIOtech NOW: The Role of Intellectual Property in Global Health

The Role of Intellectual Property in Global Health BIO is committed to increase access to biologic medicines for patients throughout the world.  As BIO President and CEO Jim Greenwood said last year when announcing our policy statement on Options for Increasing Access to Medicines in the Developing World, “We believe that the goals of increasing access to medicines, respecting intellectual property rights, and maintaining commercial viability are mutually supportive.” While there are frequent misguided calls Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Chairman Bernanke’s Speach on Government R&D Spending Policy and Economic Development

FED Chairman Ben Bernanke spoke about government funding of research and development at Georgetown University for the “New Building Blocks for Jobs and Economic Growth” conference. Highlights relating to Intellectual Property: 1.  “Economic policy affects innovation and long-run economic growth in many ways. A stable macroeconomic environment; sound public finances; and well-functioning financial, labor, and product markets all support innovation, entrepreneurship, and growth, as do effective tax, trade, and regulatory policies. Policies directed at objectives such as the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Battelle Report: $3.8 Billion Investment in Human Genome Project Drove $796 Billion in Economic Impact Creating 310,000 Jobs and Launching the Genomic Revolution

Battelle study reports the success of the Human Genome Project.  Technology Transfer at its best. $3.8 BILLION INVESTMENT IN HUMAN GENOME PROJECT DROVE $796 BILLION IN ECONOMIC IMPACT CREATING 310,000 JOBS AND LAUNCHING THE GENOMIC REVOLUTION “Genomic Revolution” Forging Major Breakthroughs in Medicine, Agriculture, Security & Justice, and Energy and Promises to Create Significantly More Jobs in the Future    WASHINGTON, D.C. — The $3.8 billion the U.S. government invested in the Human Genome Project (HGP) from 1988 Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post

NIST Report: Federal Laboratory Technology Transfer Fiscal Year 2009

The National Institute of Standards and Technology in the U.S. Department of Commerce released a report in March discussing Federal Laboratory Technology Transfer for the fiscal year 2009. The report concludes that from the years 2005-2009 the number of new inventions reported declined while new patent applications and issued patents increased.  Standard invention licensing declined while “other” licenses increased.  The report cautions that the numbers do not tell the whole story and they are working to develop Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,